David Kirn, See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 114,746 shares at $10.47 ($1.2M) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($1.2M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |